TD Capital Management’s AstraZeneca AZN Stock Holding History

TD Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.3K	Buy	+113	New	+$21.8K	﹤0.01%	350
2025 Q4	–	Sell	-113	Closed	-$17.3K	–	821
2025 Q3	$17.3K	Hold	113	–	–	﹤0.01%	349
2025 Q2	$15.8K	Buy	113 +55	+95%	+$7.71K	﹤0.01%	352
2025 Q1	$8.5K	Buy	58 +34	+142%	+$4.92K	﹤0.01%	326
2024 Q4	$3.08K	Buy	+24	New	+$3.36K	﹤0.01%	396
2023 Q3	–	Sell	-50	Closed	-$7.16K	–	413
2023 Q2	$7.16K	Hold	50	–	–	﹤0.01%	301
2023 Q1	$6.94K	Buy	+50	New	+$6.73K	﹤0.01%	296

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

TD Capital Management's AZN Position: Q1 2026 in Review

TD Capital Management opened a new position in AstraZeneca (AZN) in Q1 2026: 113 shares worth $22.3K. The stake represents ﹤0.01% of the portfolio and ranks #350 among its holdings. This is a return to the name: TD Capital Management previously reported a position in AZN as recently as Q3 2025.

TD Capital Management first reported a position in AZN in Q1 2023 and has held it in 7 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

TD Capital Management held 113 shares of AstraZeneca worth $22.3K as of Q1 2026.
AstraZeneca was a new TD Capital Management position in Q1 2026.
AstraZeneca made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #350 holding.
TD Capital Management first reported a position in AstraZeneca in Q1 2023 and has held it in 7 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.